Live feed08:30:00·151dPRReleasevia QuantisnowNew Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder CancerByQuantisnow·Wall Street's wire, on your screen.CGON· CG Oncology Inc.Health Care
